CHRW(CHRW)
CHRW
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $16.90B | $18.09B | $19.26B | $17.37B | $11.06B |
| Low | $16.44B | $16.89B | $19.25B | $16.56B | $10.55B |
| High | $17.96B | $20.10B | $19.28B | $19.01B | $12.11B |
| EBITDA Avg | $807M | $864M | $919M | $829M | $528M |
| Low | $785M | $806M | $919M | $791M | $503M |
| High | $858M | $960M | $920M | $908M | $578M |
| EBIT Avg | $722M | $773M | $823M | $742M | $472M |
| Low | $702M | $721M | $822M | $707M | $450M |
| High | $767M | $858M | $823M | $812M | $517M |
| Net Income Avg | $723M | $872M | $925M | $851M | $880M |
| Low | $672M | $686M | $878M | $799M | $827M |
| High | $767M | $974M | $1.07B | $955M | $988M |
| EPS Avg | $6.15 | $7.35 | $8.00 | $7.00 | $7.24 |
| Low | $5.53 | $5.65 | $7.23 | $6.58 | $6.80 |
| High | $6.31 | $8.02 | $8.78 | $7.86 | $8.13 |
| Analysts (Rev / EPS) | 16 / 13 | 16 / 15 | 8 / 2 | 7 / 1 | 7 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.27B | $4.40B | $4.23B | $4.27B | $4.60B | $4.66B | $4.51B | $4.80B |
| Low | $4.13B | $4.23B | $4.05B | $4.09B | $4.41B | $4.47B | $4.32B | $4.60B |
| High | $4.64B | $4.72B | $4.58B | $4.62B | $4.98B | $5.04B | $4.88B | $5.20B |
| EBITDA Avg | $204M | $210M | $202M | $204M | $219M | $222M | $215M | $229M |
| Low | $197M | $202M | $194M | $195M | $210M | $213M | $206M | $220M |
| High | $222M | $225M | $218M | $220M | $238M | $241M | $233M | $248M |
| EBIT Avg | $183M | $188M | $181M | $182M | $196M | $199M | $193M | $205M |
| Low | $176M | $181M | $173M | $175M | $188M | $191M | $185M | $197M |
| High | $198M | $201M | $195M | $197M | $212M | $215M | $208M | $222M |
| Net Income Avg | $184M | $207M | $194M | $192M | $228M | $252M | $239M | $245M |
| Low | $174M | $171M | $184M | $182M | $216M | $238M | $226M | $232M |
| High | $195M | $220M | $215M | $212M | $252M | $279M | $264M | $272M |
| EPS Avg | $1.52 | $1.71 | $1.60 | $1.58 | $1.88 | $2.08 | $1.97 | $2.03 |
| Low | $1.44 | $1.42 | $1.52 | $1.50 | $1.78 | $1.97 | $1.87 | $1.92 |
| High | $1.61 | $1.82 | $1.78 | $1.75 | $2.09 | $2.31 | $2.18 | $2.24 |
| Analysts (Rev / EPS) | 12 / 14 | 11 / 14 | 5 / 10 | 5 / 10 | 6 / 6 | 9 / 7 | 5 / 6 | 4 / 7 |